The acquisition combines IgA antibody assets and expertise of Boston-based TigaTx with Epsilogen’s assets and expertise in IgE to create the world’s leading pan-isotype cancer antibody company Allows ...
Researchers based in Austria have developed a new chromatography method for purifying secretory antibody therapies.
An IgA anti-transglutaminase 2 (TGA-IgA) antibody cut-off of approximately 6.1 times the upper limit of normal optimised celiac disease diagnosis in children and adolescents with type 1 diabetes (T1D) ...
Stocktwits on MSN
VRTX soars in extended hours after experimental drug shows positive changes in autoimmune kidney disease
Shares of Vertex Pharmaceuticals Incorporated (VRTX) rose as much as 7% after hours on Monday after the company announced ...
San Diego, CA (October 25, 2024) — IgA nephropathy (IgAN) is an autoimmune kidney disease driven by immune cells that express a protein called CD38 on their surface. A recent Phase 2 trial revealed ...
PRINCETON, N.J. & TOKYO--(BUSINESS WIRE)--Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and Otsuka Pharmaceutical, Co. Ltd. (Otsuka) announce the decision to submit a Biologics ...
IgA nephropathy (IgAN), or Berger’s disease, is a kidney condition that occurs when abnormal immunoglobulin A (IgA) antibodies trigger inflammation in the kidneys. Until recently, treatment for IgAN ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results